Antibody-based therapeutics hold great promise in treatment and prevention of multiple diseases such as cancer and infectious diseases. Effective assays for functional characterization of antibody-based therapeutics are critical due to the time- and resource- consuming process of antibody-based therapeutics discovery. There have been recent advances in assay systems in the functional characterization of antibody-based therapeutics.
Join us for this webinar with Robert Carnahan (Vanderbilt University) to discuss a cell-based platform for rapid antiviral therapeutic antibody discovery and characterization, Lauriane Cabon (Roche, Switzerland) to discuss 3D culture platforms for predicting toxicity of cancer antibody-based therapeutics, and Kyoji Tsuchikama (UTHealth) to discuss the use of live cell assays to interrogate the use of proper antibody-drug conjugate (ADC) linkers to successfully implement ADC-based chemotherapy.